US6156320A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fermented milk nutraceuticals
Assignee: Individual
•
Filing: 1997-12-05
•
Granted: 2000-12-05
•
Expires: 2017-12-05
Abstract
Abstract Methods for treating or preventing diseases or conditions, which are associated with or caused or contributed to by an opportunistic or pathogenic microorganism in a subject, comprising administering to the subject an effective amount of a culture of lactic acid fermentation microorganisms of the species Lactobacillus acidophilus are disclosed.
Inventors
- 👤 Tamara Georgievna Izvekova
- 👤 Alexandr Viktorovich Kornilov
- 👤 Irina Surenovna Amirian
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 23:42
CPC Classifications
A; A23; A23C; A23C9/00; A23C9/12; A23C9/123; A23C9/1234; A23C19/00; A23C19/02; A23C19/032; A23C19/0323; A23C9/1232; A23L; A23L33/00; A23L33/10; A23L33/135; A23L33/17; A23L33/19; A23L33/40; A23P; A23P10/00; A23P10/40; A61; A61K; A61K35/00; A61K35/66; A61K35/74; A61K35/741; A61K35/744; A61K35/747; A61P; A61P31/00; A61P31/04; A61P31/12; A61P35/00; A23V; A23V2002/00; A23V2400/00; A23V2400/11; A23V2400/113; A23V2400/181
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
49 words
A method of therapy or prophylaxis of a disease or condition, which is associated with or caused or contributed to by an opportunistic or pathogenic microorganism in a subject, comprising administering to the subject an effective amount of a culture of a Lactobacillus ocidoophilus from the Er 2 group.
Claim 2
Independent Claim
49 words
A method of therapy or prophylaxis of a disease or condition, which is associated with or caused or contributed to by an opportunistic or pathogenic microorganism in a subject, comprising administering to the subject an effective amount of a culture of a Lactobacillus ocidoophilus from the Er 2 group.
Claim 3
Dependent Claim
15 words
A method of claim 1, wherein said culture additionally comprises Lactobacillits acidophilus N.V. Er 317/402.
Claim 4
Dependent Claim
28 words
A method of claim 1 wherein the strain of the group Er-2 is selected from the group consisting of: 317/381, 317/393, 317/401, 317/396, 317/395, 317/392, 317/402 and 317/389.
Claim 5
Dependent Claim
57 words
A method of claim 1, wherein the culture comprises at least one strain of a Lactobacillus acidolphilus from the Er-2 group and a Lactobacillus acidolphilus from the strain N.V. Er 317/402, wherein the ratio of the N.V. Er 317/402 strain to the group Er-2 strain is selected from the group consisting of 1:1, 2:1, 3:1 and 4:1.
Claim 6
Dependent Claim
14 words
A method of claim 1, wherein the culture further comprises a Lactobacillus salivarius strain.
Claim 7
Dependent Claim
15 words
A method of claim 1, wherein the culture is contained in a fermented milk product.
Claim 8
Dependent Claim
31 words
A method of claim 6, wherein the fermented milk product is selected from the group consisting of: an infant formula, a fermented milk drink and a thickened semi-solid or solid composition.
Claim 9
Dependent Claim
24 words
A method of claim 7, wherein the thickened semi-solid or solid composition is selected from the group consisting of: yogurt, curd and ice cream.
Claim 10
Dependent Claim
13 words
A method of claim 1, wherein the culture is prepared as a powder.
Claim 11
Dependent Claim
45 words
A method of claim 1, wherein the disease or condition is selected from the group consisting of gastrointestinal disease, hemolytic jaundice, wound infection, omphalitis, otitis, vaginitis, urethritis, bladder infection, allergy, sinusitis, rhinitis, high serum cholesterol, atrophy, dystrophy, sepsis, colon cancer, rectal cancer and breast cancer.
Claim 12
Dependent Claim
11 words
A method of claim 1, wherein the culture is topically applied.
Claim 13
Dependent Claim
22 words
A method of claim 11, wherein the culture is prepared as an ointment, tincture, cream, gel, solution, lotion, spray, suspension or suppository.
References Cited (Backward Citations)
DE1492779A1
Cited
CH475714A
Cited
US3480443A
Cited
US3985901A
Cited
FR2290846A1
Cited
US4314995A
Cited
FR2492227A1
Cited
US4839281A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-12-05 | 2004-06-05 | 2004-12-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-12-05 | 2008-06-05 | 2008-12-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-12-05 | 2012-06-05 | 2012-12-05 | $7700.00 | Window Closed / Lapsed |